Abstract
Over the past twenty years, classifications of kidney cancer have undergone major revisions based on morphological refinements and molecular characterizations. The 2016 WHO classification of renal tumors recognizes more than 10 different renal cell carcinoma (RCC) subtypes. Furthermore, the marked inter- and intra-tumor heterogeneity of RCC is now well-appreciated. Nevertheless, contemporary multi-omics studies of RCC, encompassing genomics, transcriptomics, proteomics, and metabolomics, not only highlight apparent diversity but also showcase and underline commonality. Here, we wish to provide an integrated perspective concerning the future "functional" classification of renal cancer by bridging gaps among morphology, biology, multi-omics and therapeutics. This review focuses on recent progress and elaborates the potential value of contemporary pan-omics approaches with a special emphasis on cancer genomics unveiled through next generation sequencing technology, and how an integrated multi-omics approach might impact precision-based personalized kidney cancer care in the near future.
from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader http://ift.tt/2z2BkMN
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου